Delivery Order SPE2DB22D3401-SPE2DB24FT1QU
Award Date
1/30/24
Potential Completion Date
1/31/24
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564204015 SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML. The contract has a ceiling value of $1,149.42 and a period of performance through April 9, 2024. This award is a task order under a larger indefinite delivery contract with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, enabling...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,177.81, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2023. The contract is not designated as a set-aside, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,600.07, is a Firm Fixed Price Delivery Order for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a pharmaceutical product. The contract has a performance period through July 17, 2024 and was awarded on July 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML. The contract has a ceiling value of $3,007.89 and a period of performance ending on March 25, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and sole awardee. This delivery order is...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,538.22, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialized pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML. The contract has a ceiling value of $1,189.82 and a performance period ending on April 2, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,411.94, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,620.30, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML medical supplies. The contract has an ultimate completion date of March 17, 2025. This appears to be a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,266.97, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a migraine medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,428.34, is for the delivery of 4564885813 SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a medical product used for the treatment of migraines. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 13, 2024. The contract was awarded on June 12,...